1. Tumor entities reported by Bui‐Nguyen 2012.
Sarcoma type | Sarcoma type 'Others' | Both arms | HDCT arm | SDCT arm |
Leiomyosarcoma | ‐ | 16 | 7 | 9 |
Liposarcoma | ‐ | 10 | 6 | 4 |
Synovial sarcoma | ‐ | 9 | 2 | 7 |
Angiosarcoma | ‐ | 6 | 2 | 4 |
Malignant peripheral nerve sheath tumor | ‐ | 2 | 1 | 1 |
Clear cell sarcoma | ‐ | 1 | 1 | 0 |
Desmoplastic small round cell sarcoma | ‐ | 1 | 0 | 1 |
Rhabdomyosarcoma | ‐ | 9 | 4 | 5 |
Malignant fibrous histiocytoma | ‐ | 16 | 8 | 8 |
Extraskeletal osteosarcoma | ‐ | 1 | 0 | 1 |
Melanoma* | ‐ | 1 | 1 | 0 |
'Others' | Leiomyosarcoma | 1 | 1 | 0 |
Fibrosarcoma | 1 | 1 | 0 | |
Myofibrosarcoma | 1 | 0 | 1 | |
Undifferentiated sarcoma | 2 | 1 | 1 | |
Desmoplastic small round cell sarcoma | 2 | 2 | 0 | |
Gastrointestinal stromal tumor | 1 | 0 | 1 | |
Malignant Triton tumor | 1 | 0 | 1 | |
Unclassified sarcoma | 1 | 1 | 0 | |
Myoepithelioma* | 2 | 2 | 0 | |
Endometrial stromal sarcoma* | 3 | 1 | 2 | |
Total | 87 | 41 | 46 | |
Not listed in the WHO classification | 6 | 4 | 2 |
HDCT: high‐dose chemotherapy; SDCT: standard‐dose chemotherapy; WHO: World Health Organization.
Bui‐Nguyen: the table lists the sarcoma types assigned to each individual of all randomized participants of the study by Bui‐Nguyen 2012.
*Soft tissue sarcomas: tumor entities not listed in either versions of the WHO classification (Fletcher 2002; Fletcher 2013), or soft tissue tumors not categorized as malignant are italicized. Myoepithelioma is categorized as an intermediate soft tissue tumor. Melanoma and endometrial stromal sarcoma are not listed in the classification.